心玮医疗-B(06609.HK)盈喜：预计中期净利润不少于4000万元

Core Viewpoint - The company, Heartway Medical-B (06609.HK), expects to report a significant turnaround in its financial performance, projecting a net profit attributable to shareholders of no less than RMB 40 million for the six months ending June 30, 2025, compared to a net loss of approximately RMB 5.1 million for the corresponding period ending June 30, 2024 [1] Financial Performance - The anticipated profit and improvement in performance are primarily attributed to business growth, which has led to an increase in revenue compared to the corresponding period [1] - The overall expense ratio of the company is expected to decline, contributing to the positive financial outlook [1]